Yuan Qi Bio

Yuanqi Biology is a Shanghai-based biotechnology company specializing in high-throughput single-cell sequencing and spatial transcriptomics. Founded in 2021, the company develops proprietary microfluidic and molecular barcoding technologies to enable high-resolution analysis of cellular heterogeneity and spatial organization within tissues. Their integrated platform provides solutions for life science research, clinical diagnostics, and drug discovery, particularly in the fields of oncology and immunology. Yuanqi Biology has attracted significant investment from leading venture capital firms like Matrix Partners China and GL Ventures to advance its multi-omics technology. The company's tools are designed to accelerate the development of precision medicine by providing deep biological insights at the single-cell level. Their product portfolio includes automated instruments and specialized reagent kits for comprehensive genomic analysis.